Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Plans $9 Billion Precision Medicine Research Effort

publication date: Feb 2, 2016
China is expected to soon announce a massive investment in precision medicine, with plans to spend $9 billion over the next fifteen years. The effort will combine genomic sequencing and clinical patient data to tailor medical treatments to individuals, with the goal of improving care and curtailing waste. China's investment dwarfs a similar US initiative. One year ago, the US announced a $215 million plan, run by the National Institutes of Health, though that effort was spread over just four years. Some of China's money will be allocated to develop new drugs, based on research discoveries. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital